A Study to Evaluate the Tolerance and Pharmacokinetics of TQB2858 Injection in Subjects With Terminal Malignant Tumors

NCT04805060 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Terminal Malignant Tumors

Interventions

DRUG: TQB2858 injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.